Approval · Notice of Compliance 6267 · 2000
EQUIPOISE INJECTABLE: Notice of Compliance 6267
Issued October 13, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6267
- Date
- October 13, 2000
- Company
- Ayerst Veterinary LaboratoriesGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Anabolic steroid
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EQUIPOISE INJECTABLE | 02223619 | Cancelled Post Market |
Medicinal ingredients
- BOLDENONE UNDECYLENATE 50 MG per ML